<p>In 2018, a $25,000 grant was awarded to Dr. Mojgan Rastegar to study the role of metformin (a current and commonly available drug, used most frequently in the treatment in diabetes) as a potential therapeutic agent in the treatment of Rett Syndrome.</p>

In 2018, a $25,000 grant was awarded to Dr. Mojgan Rastegar to study the role of metformin (a current and commonly available drug, used most frequently in the treatment in diabetes) as a potential therapeutic agent in the treatment of Rett Syndrome.

Dr. Mojgan Rastegar

Interviews with grant recipients from the Ontario Rett Syndrome Association's Hope Fund.

The Hope Fund exists solely to fund Canadian research to find a cure and/or treatment for Rett syndrome. 100% of all dollars within this fund go directly to research. It is currently the only fund dedicated to Rett syndrome research in Canada.

Since the creation of The Hope Fund in 2014, ORSA has awarded over $600,000 in research grants.

To help fund The Hope Fund, please make a donation at rett.ca/donate.

Medicine

Health & Fitness

Education

Interviews with grant recipients from the Ontario Rett Syndrome Association's Hope Fund. The Hope Fund exists solely to fund Canadian research to find a cure and/or treatment for Rett syndrome. 100% of all dollars within this fund go directly to research. It is currently the only fund dedicated to Rett syndrome research in Canada. Since the creation of The Hope Fund in 2014, ORSA has awarded over $600,000 in research grants. To help fund The Hope Fund, please make a donation at rett.ca/donate.

Share Dr. Mojgan Rastegar

Sign up to save your podcasts

Dr. Mojgan Rastegar

Dr. Mojgan Rastegar